FierceBiotech

The planned closure of Bio Palette has triggered the termination [...]

After 27 years with Bavarian Nordic, including 12 as CEO, [...]

Zealand Pharma’s Roche-partnered amylin analog demonstrated “placebo-like tolerability” and up [...]

In a strikingly blunt briefing, a senior FDA official accused [...]

Merck KGaA is no longer pursuing clinical-stage candidates obtained through [...]

Flagship Pioneering-backed Alltrna is once again laying off staff, this [...]

The back-and-forth between the FDA and gene therapy developer uniQure [...]

Cardiovascular biotech Tenaya Therapeutics has signed a research collaboration agreement [...]

After steering positive key pivotal readouts for a trio of [...]

Roche is plugging 710 billion won (about $484 million) into [...]